Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Alzheimer's disease
Alzheimer's disease
Alzheon steps back from an IPO, further than ever from a PhIII Alzheimer’s study
Endpoints
Sat, 04/28/18 - 11:47 am
Alzheon
Alzheimer's disease
clinical trials
ALZ-801
IPOs
Anticholinergic drugs may induce dementia
GoinPharma
Sat, 04/28/18 - 11:44 am
dementia
Alzheimer's disease
anticholinergics
After yet another PhIII Alzheimer’s failure, experts try to map a path out of the wrecking field
Endpoints
Tue, 04/10/18 - 11:19 am
FDA
Alzheimer's disease
R&D
NIH
biomarkers
vTv therapeutics Alzheimer's Drug Fails to Reach Primary Endpoints in Ph III study
CP Wire
Mon, 04/9/18 - 09:26 pm
vTv Therapeutics
azeliragon
Alzheimer's disease
vTv therapeutics Alzheimer's Drug Fails to Reach Primary Endpoints in Ph III study
Mon, 04/9/18 - 08:21 pm
vTv Therapeutics
azeliragon
Alzheimer's disease
What if we have got it wrong on Alzheimer's?
Sydney Herald
Sun, 03/25/18 - 11:21 am
Alzheimer's disease
Pfizer
anti-amyloid
Americans With Alzheimer's Now Number 5.7 Million
Forbes
Sun, 03/25/18 - 11:19 am
Alzheimer's disease
Prothena, Celgene ink neuro R&D pact potentially worth $2B+
Fierce Biotech
Wed, 03/21/18 - 09:20 am
Prothena
Celgene
R&D
TDP-43
anti-tau antibodies
Alzheimer's disease
Denali Therapeutics starts testing novel approach to fight Alzheimer’s
GoinPharma
Wed, 03/21/18 - 09:16 am
Denali Therapeutics
Alzheimer's disease
DNL747
Teva Pharmaceutical
Alzheimer's Costs Reach $277 Billion
Forbes
Tue, 03/20/18 - 09:39 am
Alzheimer's disease
healthcare costs
Alzheon Files for IPO to Fund Studies of Amyloid Alzheimer’s Drug
Xconomy
Sun, 03/18/18 - 11:30 am
Alzheon
Alzheimer's disease
IPOs
ALZ-801
With $69M Deal, AbbVie Turns to Voyager for an Alzheimer’s Gene Therapy
Xconomy
Tue, 02/20/18 - 10:58 pm
AbbVie
Voyager Therapeutics
gene therapy
Alzheimer's disease
Biogen’s key Alzheimer’s disease drug is facing potential signs of trouble
Marketwatch
Sun, 02/18/18 - 10:12 am
Biogen
Alzheimer's disease
aducanumab
FDA looks to pave way for earlier-stage Alzheimer's drugs
Yahoo/Reuters
Fri, 02/16/18 - 09:26 am
FDA
Alzheimer's disease
drug development
Biogen tweaks Alzheimer’s phase 3, sparking stock slide
Fierce Biotech
Thu, 02/15/18 - 09:39 am
Biogen
Alzheimer's disease
clinical trials
aducanumab
Merck scraps another late-stage Alzheimer's drug study
Yahoo/Reuters
Wed, 02/14/18 - 11:55 pm
Merck
Alzheimer's disease
verubecestat
Merck just dashed the last remaining hopes for its industry-leading BACE drug for Alzheimer’s
Endpoints
Tue, 02/13/18 - 11:14 pm
Merck
BACE inhibitors
Alzheimer's disease
verubecestat
Boehringer ends Alzheimer's research for PDE9 blocker
Biopharma Dive
Sat, 02/10/18 - 09:22 am
Boehringer Ingelheim
Alzheimer's disease
PDE9 blockers
BI 409306
The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease
Yahoo/Benzinga
Fri, 02/9/18 - 12:00 am
Alzheimer's disease
R&D
Namzaric-maker Allergan aims hopeful Alzheimer’s message at caregivers
Fierce Pharma
Wed, 01/31/18 - 10:58 am
Namzaric
Allergan
Alzheimer's disease
drug ads
Pages
« first
‹ previous
…
33
34
35
36
37
38
39
40
41
…
next ›
last »